Article: Prostatitis, prostate hypertrophy, and prostate cancer.

Article: Spectrum Pharmaceuticals Initiates Phase 2b Trial for Ozarelix in ...
PR Newswire;  January 25, 2007 ;     700+ words ... ... study of ozarelix in the U.S. in patients with benign prostate hypertrophy (BPH). The trial will be conducted in accordance with ... benign prostatic hypertrophy (BPH), hormone-dependent prostate cancer and other indications. About Benign Prostatic Hypertrophy ...

Article: Spectrum Pharmaceuticals Announces FDA's Acceptance of Ozarelix ...
PR Newswire;  January 3, 2007 ;     700+ words ... ... Investigational New Drug (IND) application for ozarelix in Benign Prostate Hypertrophy (BPH) and that the FDA has approved the protocol for ... benign prostatic hypertrophy (BPH), hormone-dependent prostate cancer and other indications. About Benign Prostatic Hypertrophy ...

Article: Spectrum Announces Completion Of Target Enrollment In Ozarelix ...
PR Newswire;  May 1, 2007 ;     700+ words ... ... Nippon Kayaku, a key player in the Japanese oncology market. Spectrum is developing ozarelix for BPH, hormone-dependent prostate cancer and other indications. About Benign Prostatic Hypertrophy Benign prostatic hypertrophy is a non-cancerous enlargement ...

Article: Benign prostate hypertrophy.(Life Extension)
Manila Bulletin;  October 25, 2006 ;     700+ words ...Byline: GARY S. SY NEARLY every man over 45 has some degree of enlargement of the prostate gland, which slowly progresses with age. Harmless overgrowth of normal prostate tissue is a natural result of aging. Prostate gland is not one single gland, but a cluster of small glands that surrounds the

Article: 1-^sup 11^C-Acetate Kinetics of Prostate Cancer
The Journal of Nuclear Medicine;  February 1, 2008 ;     700+ words ... ... with primary prostate cancer, 10 with recurrent ... with benign prostate hypertrophy were studied ... acetate; PET; prostate cancer; benign prostate hypertrophy; kinetic modeling ... 107.044453 Prostate cancer is common in ...

Article: Spectrum Authorized by FDA to Conduct Phase I/II Clinical Trial ...
PR Newswire;  May 31, 2005 ;     700+ words ... ... Indications; Hormone Dependent Prostate Cancer and Benign Prostate Hypertrophy (BPH) IRVINE, Calif ... with hormone-dependent prostate cancer in the United States ... initiated clinical studies in prostate cancer and in benign prostatic ...

Article: MEN COPE WITH PROSTATE CANCER BY TURNING TO SUPPORT ...
The Virginian Pilot;  May 31, 1998 ;     700+ words ... ... looking to establish a prostate cancer support group. Those ... LOOK FOR Symptoms of prostate cancer are often associated with benign prostate hypertrophy (BPH), an excess ... distinguish between prostate cancer and BPH. The American ...